Categorical Variable | Group 1 (n = 23) HFI absent | Group 2 (n = 29) HFI present | Total (n = 52) | p |
---|---|---|---|---|
n(%) | ||||
Sex (female) | 16(69.6) | 18(62.1) | 34(65.4) | 0.571 |
HFI Type | ||||
A | N/A | 15(51.7) | N/A | N/A |
B | 6(20.7) | |||
C | 6(20.7) | |||
D | 2(6.9) | |||
T2D (absent/present) | 14(60.9)/9(39.1) | 13(44.8)/16(55.2) | 27(51.9)/25(48.1) | 0.249 |
Hypothyroidism (absent/present) | 16(69.6)/7(30.4) | 18(62.1)/11(37.9) | 34(65.4)/18(34.6) | 0.571 |
Hypogonadism (absent/present) | 11(47.8)/12(52.2) | 18(62.1)/11(37.9) | 29(55.8)/23(44.2) | 0.304 |
Treatment Modality | ||||
Medical | 4(17.4) | 3(10.3) | 7(13.5) | 0.461 |
Both surgical and medical | 19(82.6) | 26(89.7) | 45(86.5) | |
Microadenoma/Macroadenoma | 1(4.3)/22(95.7) | 4(13.8)/25(86.2) | 5(9.6)/47(90.4) | 0.233 |
Disease Control | ||||
Controlled | 17(73.9) | 19(65.5) | 36(69.2) | 0.513 |
Uncontrolled | 6(26.1) | 10(34.5) | 16(30.8) |